Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

39 results
  1. ... designed to test the hypothesis that NSAIDs, either selective (celecoxib) or nonselective (naproxen) cyclooxygenase-2 inhibitors, would work for the primary prevention of CATD. 255 – 258 The trial had three ...
  2. ... Scheiman JM, Yeomans ND, Talley NJ, et al. Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors. Am J Gastroenterol. 2006 Apr;101(4):701– ...
  3. ... Vakil N, Chan FK, Tulassay Z, et al. Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors. American Journal of Gastroenterology. 2006; 101 (4):701– ...
  4. ... Thai. 2009] Gastrointestinal and cardiovascular risk of non-selective NSAIDs and ... for the Prevention of Morbidity and Mortality From Preeclampsia: A Systematic ...
  5. ... randomized trial of low-dose aspirin in the prevention of clinical type 2 diabetes in women. ... inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal ...
  6. ... the overall pooled estimate for all COX-2 selective NSAIDs, and just met criteria ... COX-2 inhibitor, nor were estimates of CV risk with specific ...
  7. ... explicitly referred to K.6. Non-specialist management – selective COX-2 inhibitors View in own window Reference Reason for exclusion ... 33-37 All participants had already tolerated a selective COX-2 inhibitor Di Leo E, Aloia AM, Nettis E, Cardinale ...
  8. ... rebamipide add-on therapy in arthritic patients with COX-2 selective inhibitor-related gastrointestinal events: a prospective, randomized, open-label ...
  9. ... and Tree Locations Celecoxib A pyrazole derivative and selective CYCLOOXYGENASE 2 INHIBITOR that is used to treat symptoms associated with ... with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients ... CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used ...
  10. ... double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut ...
previous · 1 · 2 · 3 · next